NEWS
Apteeus celebrates its 10th anniversary
It is with immense pride that we celebrate today a decade of discoveries and progress…
The ? The peroxisome !
For several years, the history of Apteeus has led us to specialize in techniques for…
8.8 million euros for accelerated drug repurposing for rare neurological disorders
APTEEUS has received funding from the frontiers in Research Fund (NFRF) – 2022 Horizon Global…
In 2023, we will again associate empathy and humanity with our discoveries and our achievements. Apteeus wish you the best!
2023 is an important year for Apteeus. Our role as scientific support and our integration…
15th edition of the Rare Disease Day
On the occasion of the 15th edition of the Rare Diseases awareness campaign which took…
The beginning of clofoctol story in covid19
You will read why we decided to run clinical trials with clofoctol in covid19… Large…
HERE WE ARE, THE CLOFOCTOL TRIAL IN COVID19 WILL BEGIN!
The entire Apteeus team is delighted with this news. After months of fundraising, designing the…
Personalized research delivered a candidate therapy for Calixte, Satine, Adeline and others
“Thanks to a technology based on mass spectrometry, we were able, in less than 10…
CoViD project, the clinical trial became a national priority
Since March 2020, we have been working on the repositioning of a drug against CoViD19,…
A new European policy framework for Rare Disorders
We are happy to find Apteeus’ commitments among the 8 recommendations of Rare2030: establish partnerships…
Why is #Apteeus engaged in research against the # COVID19 pandemic?
Responding quickly to an important medical need has been the commitment of APTEEUS for several…
APTEEUS will make available to the Task Force Corona of the Institut Pasteur de Lille, its unique collection of molecules approved for a human use.
Several research teams from the Institut Pasteur de Lille are currently working on the #Covid19…
Rare diseases! not so rare…APTEEUS is starting two new projects
APTEEUS is currently starting two new challenges aimed at repositioning drugs for children suffering from…
Identification of an experimental treatment for Noé
Already implemented for several patients, Apteeus’ technology has just identified a drug that could improve…
Project manager position
APTEEUS is seeking a new collaborator to manage new projects of individualized drug discovery. See…
RARE DISEASE DAY
We are not patients, we are not families, we are not doctors…but we live with…
APTEEUS, European Venture Contest Finalist
APTEEUS has been awarded at the France Tech Transfer Invest 2019. France Tech Transfer Invest…
We can’t wait for 2019
Apteeus has started a tailor-made research program for the association Les Petits Mec P2. Less…
APTEEUS will attend the European Conference on Rare Diseases and Orphan Products in Vienne
Rare Disease 360°, Collaborative Strategies to leave no-one behind Proud to present the high potential…
HAPPY NEW YEAR !
Camille, Isabelle, Loïc, Simon, Benoit and Terence wish you all the best for 2018.
The first edition of Hibster
The first edition of Hibster is 120 brains in turmoil, 48h of thinking for unlimited…
APTEEUS, Laureate of the Concours Mondial de l’Innovation 2030
This is thanks to an innovative strategy of Individualized Medicine, that the pair of Pharmacists,…
Lille Metropole Innovation
December 4, 2014, Benoit and Terence presented APTEΞUS activity to the LMI committee (Lille Metropole Innovation).…
Biotech Finances
APTEEUS pushes the boundaries of personalized medicine.